Abstract:Modern contraceptive methods represent more than a technical advance: they are the instrument of a true social revolution-the "first reproductive revolution" in the history of humanity, an achievement of the second part of the 20th century, when modern, effective methods became available. Today a great diversity of techniques have been made available and-thanks to them, fertility rates have decreased from 5.1 in 1950 to 3.7 in 1990. As a consequence, the growth of human population that had more than tripled, from 1.8 to more than 6 billion in just one century, is today being brought under control. At the turn of the millennium, all over the world, more than 600 million married women are using contraception, with nearly 500 million in developing countries. Among married women, contraceptive use rose in all but two developing countries surveyed more than once since 1990. Among unmarried, sexually active women, it grew in 21 of 25 countries recently surveyed. Hormonal contraception, the best known method, first made available as a daily pill, can today be administered through seven different routes: intramuscularly, intranasally, intrauterus, intravaginally, orally, subcutaneously, and transdermally. In the field of oral contraception, new strategies include further dose reduction, the synthesis of new active molecules, and new administration schedules. A new minipill (progestin-only preparation) containing desogestrel has been recently marketed in a number of countries and is capable of consistently inhibiting ovulation in most women. New contraceptive rings to be inserted in the vagina offer a novel approach by providing a sustained release of steroids and low failure rates. The transdermal route for delivering contraceptive steroids is now established via a contraceptive patch, a spray, or a gel. The intramuscular route has also seen new products with the marketing of improved monthly injectable preparations containing an estrogen and a progestin. After the first device capable of delivering progesterone directly into the uterus was withdrawn, a new system releasing locally 20 microg evonorgestrel is today marketed in a majority of countries with excellent contraceptive and therapeutic performance. Finally, several subcutaneously implanted systems have been developed: contraceptive "rods," where the polymeric matrix is mixed with the steroid and "capsules" made of a hollow polymer tube filled with free steroid crystals. New advances have also been made in nonhormonal intrauterine contraception with the development of "frameless" devices. The HIV/AIDS pandemic forced policy makers to look for ways to protect young people from sexually transmitted diseases as well as from untimely pregnancies. This led to the development of the so-called dual protection method, involving the use of a physical barrier (condom) as well as that of a second, highly effective contraceptive method. More complex is the situation with antifertility vaccines, still at a preliminary stage of development and unlikely to be in widespread use for years to come. Last, but not least, work is in progress to provide effective emergency contraception after an unprotected intercourse. Very promising in this area is the use of selective progesterone receptor modulators (antiprogestins).

The role of the World Health Organization in male contraceptive development

The role of advocacy in sustaining male contraceptive research and development

Factors influencing contraception choice and use globally: a synthesis of systematic reviews

Creating a Global Legal and Policy Database and Document Repository: Challenges and Lessons Learned From the World Health Organization Sexual, Reproductive, Maternal, Newborn, Child and Adolescent Health Policy Survey

The role of community-based health planning and services strategy in involving males in the provision of family planning services: a qualitative study in Southern Ghana

Male contraceptive acceptability versus male acceptance of contraceptive responsibility

Socioeconomic determinants of male contraceptive use in South Africa: a secondary analysis of the 2016 SADHS data

Male Partner Involvement in Prevention of Mother to Child Transmission of HIV in Sub-Saharan Africa: Successes, Challenges and Way Forward

Strengthening Health Systems in Humanitarian Settings: Multi-Stakeholder Insights on Contraception and Postabortion Care Programs in the Democratic Republic of Congo and Somalia

Defining counselling in contraceptive information and services: outcomes from an expert think tank

Factors Associated with Contraceptive Use in Sub-Saharan Africa

Gendered power dynamics and women’s negotiation of family planning in a high HIV prevalence setting: a qualitative study of couples in western Kenya

The male birth control pill – A new approach to family planning and population control

Understanding barriers to men's support for family planning in rural Ethiopia-findings from the USAID Transform: Primary Health Care Project Gender Analysis

Masculinities and sexual and reproductive health and rights: a global research priority setting exercise

Contraception Today

Male partner involvement in health interventions: A systematic review of best practices in Sub-Saharan Africa

Contraceptive dynamics among women with disabilities in low- and middle-income countries: a scoping review protocol

Engaging Men in Family Planning: Perspectives From Married Men in Lomé, Togo

Assessment of demand for male contraceptives: A multi‐country study

Gendered health institutions: examining the organization of health services and men's use of HIV testing in Malawi